$NNE

Nano Nuclear Energy Inc.

CIK:0001923891|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 214,042		$ 214,042
Cost of revenue	(151,831)		(151,831)
Gross margin	62,211		62,211
General and administrative	11,860,371	5,324,260	27,336,285	23,516,008
Research and development	3,994,448	3,666,513	15,054,286	11,283,979
Change in fair value of contingent consideration	33,000	401,500	(871,000)	1,004,000
Loss from operations	(15,825,608)	(9,392,273)	(41,457,360)	(35,803,987)
Other income	5,373,727	1,797,690	15,336,389	3,787,321
Accretion of deferred consideration	(27,349)		(27,349)
Unrealized gain on marketable securities	375,095		195,225
Gain on settlement of accounts receivable			152,515
Net loss	(10,104,135)	(7,594,583)	(25,800,580)	(32,016,666)
Other comprehensive income (loss):
Cumulative translation adjustment	10,333		5,543
Comprehensive loss	$ (10,093,802)	$ (7,594,583)	$ (25,795,037)	$ (32,016,666)
Net loss per share of common stock:
Basic	$ (0.19)	$ (0.19)	$ (0.50)	$ (0.87)
Diluted	$ (0.19)	$ (0.19)	$ (0.50)	$ (0.87)
Weighted-average shares of common stock outstanding:
Basic	52,345,865	38,985,143	51,260,663	36,663,325
Diluted	52,345,865	38,985,143	51,260,663	36,663,325

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Sep. 30, 2025
OPERATING ACTIVITIES
Net loss	$ (10,104,135)	$ (7,594,583)	$ (25,800,580)	$ (32,016,666)	$ (40,067,076)
Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation			7,026,936	17,454,842
Amortization of right-of-use assets			262,369	214,228
Amortization of intangible assets			53,851
Accretion of deferred consideration	27,349		27,349
Depreciation			721,000	147,853
Changes in fair value of contingent liability	33,000	401,500	(871,000)	1,004,000
Bank revaluation			16,752
Unrealized gain on marketable securities	(375,095)		(195,225)
Non-cash interest income on short-term investments			(306,952)
Gain on settlement of accounts receivable			(152,515)
Change in assets and liabilities:
Prepaid and other current assets			(2,446,736)	(586,137)
Deposits			(4,766)	(384,000)
Accounts receivable			10,467	(250,000)
Accounts payable and accrued liabilities			3,282,453	(164,027)
Due to related parties				16,667
Lease liabilities			(287,887)	(150,269)
Net cash used in operating activities			(18,664,484)	(14,713,509)	(19,621,963)
INVESTING ACTIVITIES
Purchase of short-term investments, net of maturities			(281,212,550)
Additions to property, plant and equipment			(9,827,509)	(3,801,474)
Deposits			(800,000)
Acquisition of business, net of cash acquired			(5,776,308)
In-process research and development				(9,075,045)
Net cash used in investing activities			(297,616,367)	(12,876,519)
FINANCING ACTIVITIES
Proceeds from common stock issuances			426,750,033	206,400,015
Offering costs			(22,674,963)	(15,076,556)
Proceeds from exercise of warrants			2,473,548	15,657,187
Proceeds from exercise of stock options			4,650,000	2,284,500
Deferred Financing Costs			300,000
Net cash provided by financing activities			411,498,618	209,265,146
Net increase (decrease) in cash and cash equivalents			95,217,767	181,675,118
Cash and cash equivalents, beginning of period			203,265,052	28,507,257	28,507,257
Effect of exchange rate changes on cash			(11,212)
Cash and cash equivalents, end of period	$ 298,471,607	$ 210,182,375	298,471,607	210,182,375	$ 203,265,052
Non-cash transactions:
Common stock issued as business acquisition consideration			1,031,270
Deferred business acquisition stock consideration payable			3,312,127
Right-of-use assets acquired in business acquisition			330,154
Inception of Right-of-Use Asset / Liability				1,026,348
Supplemental disclosures of cash flow information
Cash paid for income taxes			$ 1,755,746	$ 56,717

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Sep. 30, 2025
Current assets:
Cash and cash equivalents	$ 298,471,607	$ 203,265,052
Short-term investments	281,519,503
Accounts receivable, net	291,451	250,000
Prepaid and other current assets	3,359,164	902,861
Deposits, current	1,050,000	250,000
Marketable securities, at fair value	597,740
Total current assets	585,289,465	204,667,913
Deferred offering costs		300,000
Deposits, non-current	274,001	269,235
Property, plant and equipment, net	18,975,301	9,783,777
Right-of-use assets	2,628,681	2,560,896
Long-term investments, related party	2,000,000	2,000,000
Goodwill	4,240,900
Intangible assets	5,546,149
In-process research and development	9,075,045	9,075,045
Total assets	628,029,542	228,656,866
Current liabilities:
Accounts payable and accrued liabilities	4,714,743	1,314,596
Lease liabilities, current	636,871	534,128
Deferred acquisition consideration, current	933,571
Contingent consideration	1,107,000	1,978,000
Total current liabilities	7,392,185	3,826,724
Lease liabilities, non-current	2,200,937	2,261,414
Deferred acquisition consideration, non-current	2,405,905
Total liabilities	11,999,027	6,088,138
Stockholders’ equity
Preferred stock, $0.0001 par value; 25,000,000 authorized as of June 30, 2026 and September 30, 2025; none issued and outstanding as of June 30, 2026 and September 30, 2025
Common stock, $0.0001 par value; 275,000,000 authorized as of June 30, 2026 and September 30, 2025; 53,698,146 and 41,738,358 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively	5,370	4,173
Additional paid-in capital	699,321,039	280,065,412
Accumulated deficit	(83,301,437)	(57,500,857)
Accumulated other comprehensive income	5,543
Total stockholders’ equity	616,030,515	222,568,728
Total liabilities and stockholders’ equity	$ 628,029,542	$ 228,656,866